SAFETY AND EFFICACY 31 WEEK DATA OF ANAVEX 2-73 IN A PHASE 2A STUDY IN MILD-MODERATE ALZHEIMER’S DISEASE PATIENTS

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 12; no. 7; p. P1174
Main Authors Macfarlane, Stephen, Cecchi, Marco, Moore, Dennis, Maruff, Paul, Zografidis, Tasos, Missling, Christopher
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.07.2016
Subjects
Neurology
Online AccessGet full text

Cover

More Information
ISSN:1552-5260
1552-5279
DOI:10.1016/j.jalz.2016.07.101